News &amp; Updates

Individuals with high body mass index (BMI) often eat delivery and takeaway meals, while those with low BMI and percent body fat usually consume homecooked meals, a UK study has found.

Takeaway, delivery meals may make you fat, says study

PPI use not linked to cardiovascular disease risk

The association between proton pump inhibitor (PPI) use and increased cardiovascular disease risk, as seen in many observational studies, is probably caused by residual confounding related to conditions with PPI treatment instead of a true correlation, as suggested by negative findings in a self-controlled case series (SCCS) study.

PPI use not linked to cardiovascular disease risk

Weekly dose-dense CT does not confer survival benefit for ovarian cancer patients

In the final analysis of the phase III ICON8* study, a weekly dose-dense chemotherapy (CT) regimen comprising paclitaxel and carboplatin did not improve survival outcomes in women with epithelial ovarian cancer** compared with the standard first-line (1L) paclitaxel-carboplatin regimen given once every 3 weeks (Q3W).

Weekly dose-dense CT does not confer survival benefit for ovarian cancer patients

18 Jul 2022

Six in 10 preschoolers exceed recommended screen time limit

Nearly all preschool-aged children use electronic screen devices, while 60 percent go beyond the daily recommended limit, according to a recent study.

Six in 10 preschoolers exceed recommended screen time limit

Pembrolizumab looks good for treated, advanced MSI-H/dMMR endometrial cancer

Use of pembrolizumab helps maintain or improve health-related quality of life in patients with previously treated, advanced endometrial cancer characterized by high levels of microsatellite instability (MSI) or deficient mismatch repair (MSI-H/dMMR), according to data from the phase II KEYNOTE-158 study.

Pembrolizumab looks good for treated, advanced MSI-H/dMMR endometrial cancer

18 Jul 2022

Frailty modifies treatment effect of exercise training in patients with chronic stable HFrEF

For frail patients with chronic stable heart failure (HF) with reduced ejection fraction (HFrEF), aerobic exercise training confers significant reduction in the risk of all-cause hospitalization but not mortality, a study reports.

Frailty modifies treatment effect of exercise training in patients with chronic stable HFrEF

Less liver fat, better glucose control with LCHF diet

A low-carbohydrate, high-fat (LCHF) diet averts disease progression in patients with nonalcoholic fatty liver disease (NAFLD) in a new study presented at ILC 2022.

Less liver fat, better glucose control with LCHF diet

Original New Drug Application Approvals by US FDA (01 - 15 July 2022)

New drug applications approved by US FDA as of 01 - 15 July 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01 - 15 July 2022)

Coffee intake may reduce ischaemic heart disease mortality risk

Despite apparent reversals in the direction of their interaction over the years, coffee intake remains inversely associated with ischaemic heart disease mortality on a country-level, reports a recent study.

Coffee intake may reduce ischaemic heart disease mortality risk

Eosinophilic esophagitis patients at greater risk of later psychiatric disorder

The risk of psychiatric disease is higher in individuals with eosinophilic esophagitis (EoE) compared to their siblings and the general population, reveals a study. This risk must be addressed in clinical care to detect, prevent, and treat comorbidity.

Eosinophilic esophagitis patients at greater risk of later psychiatric disorder